AVS Bio, a supplier of bioprocessing inputs owned by Arlington Capital Partners, has acquired Biorbyt, a supplier of research reagents. Biorbyt sells more than 1 million antibodies, proteins, ELISA kits and molecular biology products through its e-commerce platform to pharmaceutical and biotech companies and academic institutions worldwide. Founded in 2011, the company is based in Cambridge, U.K.
Biorbyt will continue to operate under its existing leadership, including co-founders Tillmann Ziegert and Qun Yang, as part of AVS Bio. Headquartered in Norwich, Conn., AVS Bio makes specific-pathogen-free eggs, cell products, antibodies and proteins at more than 20 facilities in North America and Europe. AVS Bio CEO Jac Price said the deal moves the company toward becoming a diversified global biomaterials provider, and Arlington partner Malcolm Little said Biorbyt will broaden AVS Bio’s product offering. Arlington is based in Washington, D.C.
